Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Stannous Fluoride Dentifrice on Dentinal Hypersensitivity
NCT06244290Phase 3
Key facts
- Status
- Completed
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Countries
- 1
- Sponsor
- Colgate-Palmolive
- Modality
- DNA Intercalators/Alkylators
- Drugs
- stannous fluoride
- Conditions
- Dentinal hypersensitivity (DH)
01
Overview
Phase 3 trial of stannous fluoride in Dentinal hypersensitivity (DH) (3 arms), sponsored by Colgate-Palmolive. Primary endpoints: Tactile dentin hypersensitivity at 7 days and Air blast dentin hypersensitivity at 7 days. Started Sep 2020; status: completed.
02
Design
3 armsColgate SNF
Colgate SnF Toothpaste with Colgate Adult Extra Clean soft-bristle toothbrush
Sensodyne Extra Whitening
Sensodyne Extra Whitening Toothpaste with Colgate Adult Extra Clean soft-bristle toothbrush
Colgate Fluoride (CDC)
Colgate Fluoride Toothpaste (CDC) with Colgate Adult Extra Clean soft-bristle toothbrush
03
Who it enrols
Adults aged 18-70 in good general health with at least two sensitive teeth demonstrating dentin exposure and qualifying hypersensitivity responses to tactile and air blast stimuli, excluding those with gross oral pathology, recent use of desensitizing treatments, or advanced periodontal disease.
04
Endpoints
Primary
Tactile dentin hypersensitivity
Air blast dentin hypersensitivity
Beyond the preview
Go deeper on NCT06244290.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06244290.